KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) EPS (Weighted Average and Diluted) (2016 - 2025)

Cvs Health (CVS) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $2.32 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 77.1% year-over-year to $2.32, compared with a TTM value of $1.39 through Dec 2025, down 62.02%, and an annual FY2025 reading of $1.39, down 62.02% over the prior year.
  • EPS (Weighted Average and Diluted) was $2.32 for Q4 2025 at Cvs Health, up from -$3.14 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.32 in Q4 2025 and bottomed at -$3.14 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.04, with a median of $1.44 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 167.31% in 2023, then tumbled 4585.71% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $1.04 in 2021, then skyrocketed by 70.19% to $1.77 in 2022, then decreased by 10.17% to $1.59 in 2023, then dropped by 17.61% to $1.31 in 2024, then skyrocketed by 77.1% to $2.32 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CVS at $2.32 in Q4 2025, -$3.14 in Q3 2025, and $0.8 in Q2 2025.